MADRIGAL PHARMACEUTICALS, INC. short interest in 2025
In 2025, MADRIGAL PHARMACEUTICALS, INC.'s disclosed short interest ran from 18.72% of shares outstanding on 15 Jan 2025 to 16.34% on 31 Dec 2025, a change of -2.38 percentage points. The year's high was 18.77% on 14 Mar 2025 and its low 16.34% on 31 Dec 2025, averaging 17.58% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.96 days on 31 Mar 2025. Full history: MADRIGAL PHARMACEUTICALS, INC..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 18.72% (15 Jan 2025)
- End of year
- 16.34% (31 Dec 2025)
- Change
- -2.38 pp
- High
- 18.77% (14 Mar 2025)
- Low
- 16.34% (31 Dec 2025)
- Average
- 17.58%
- Highest days to cover
- 16.96 (31 Mar 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 18.72% | 8.98 | results (8-K) |
| 31 Jan 2025 | 18.26% | 8.56 | |
| 14 Feb 2025 | 17.40% | 10.70 | |
| 28 Feb 2025 | 17.21% | 8.71 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 18.77% | 8.53 | |
| 31 Mar 2025 | 18.33% | 16.96 | |
| 15 Apr 2025 | 18.46% | 11.51 | |
| 30 Apr 2025 | 18.49% | 11.43 | |
| 15 May 2025 | 18.02% | 10.33 | 10-Q filed, results (8-K) |
| 30 May 2025 | 17.50% | 12.08 | |
| 13 Jun 2025 | 18.70% | 13.88 | |
| 30 Jun 2025 | 17.87% | 12.18 | |
| 15 Jul 2025 | 17.06% | 16.04 | |
| 31 Jul 2025 | 17.93% | 8.83 | |
| 15 Aug 2025 | 17.02% | 8.36 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 18.16% | 9.29 | |
| 15 Sep 2025 | 18.56% | 12.75 | |
| 30 Sep 2025 | 16.70% | 10.88 | |
| 15 Oct 2025 | 16.55% | 13.94 | |
| 31 Oct 2025 | 16.45% | 12.67 | |
| 14 Nov 2025 | 16.67% | 7.38 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 16.38% | 9.96 | |
| 15 Dec 2025 | 16.37% | 14.03 | |
| 31 Dec 2025 | 16.34% | 13.07 |
See also: MADRIGAL PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.